Novo Nordisk's New Obesity Pill Beats Wegovy In Early Trial

ToplineShares of Danish pharma giant Novo Nordisk soared to a record high on Thursday after it reported promising data on a new weight loss pill, a sign of the company’s plans to cement its prime position in the burgeoning obesity drug market in the face of stiff competition from industry titans like Eli Lilly and an array of smaller biotech startups.Early data on the pill suggested it may outperform Wegovy, an injectable prescription weight loss ... [+] medicine.UCG/Universal Images Group via Getty Images ...